Infectious Respiratory Disease Diagnostics Market 2025 to 2034
Infectious Respiratory Disease Diagnostics Market 2025 to 2034
Infectious Respiratory Disease Diagnostics Market (By Product Type: Instruments, Consumables, Services; By Sample Type: Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others; By Application: COVID-19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, Other; By Technology: Immunoassay, Molecular Diagnostics, Microbiology, Other; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 57.55 Bn
Forecast Year, 2034
USD 91.91 Bn
CAGR, 2025 - 2034
5.34%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global infectious respiratory disease diagnostics market, valued at over USD 57.55 billion in 2025, is projected to reach USD 91.91 billion by 2034, expanding at a CAGR of 5.34%, driven by rising respiratory infections and advanced diagnostic adoption.
Infectious Respiratory Disease Diagnostics Market Size Analysis
Infectious Respiratory Disease Diagnostics Market Size By Product Type 2025 to 2034 (USD Billion)
| Product Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 9.69 | 10.25 | 10.74 | 11.24 | 11.84 | 12.48 | 13.10 | 13.88 | 14.65 | 15.47 |
| Consumables | 19.15 | 20.16 | 21.23 | 22.46 | 23.69 | 24.83 | 26.19 | 27.63 | 29.10 | 30.64 |
| Services | 28.71 | 30.21 | 31.90 | 33.57 | 35.34 | 37.34 | 39.35 | 41.33 | 43.50 | 45.81 |
Infectious Respiratory Disease Diagnostics Market Size By Sample Type 2025 to 2034 (USD Billion)
| Sample Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Saliva | 3.85 | 4.04 | 4.29 | 4.55 | 4.72 | 5.04 | 5.24 | 5.59 | 5.88 | 6.21 |
| Nasopharyngeal Swabs (NPS) | 7.67 | 8.08 | 8.56 | 9.01 | 9.48 | 9.93 | 10.55 | 11.08 | 11.66 | 12.24 |
| Anterior Nasal Region | 11.51 | 12.16 | 12.76 | 13.41 | 14.20 | 14.96 | 15.69 | 16.54 | 17.43 | 18.35 |
| Blood | 15.34 | 16.14 | 16.99 | 17.91 | 18.88 | 19.87 | 21.00 | 22.05 | 23.27 | 24.51 |
| Others | 19.17 | 20.20 | 21.26 | 22.40 | 23.59 | 24.84 | 26.17 | 27.58 | 29.01 | 30.61 |
Infectious Respiratory Disease Diagnostics Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 | 2.73 | 2.89 | 3.08 | 3.24 | 3.39 | 3.57 | 3.79 | 3.99 | 4.21 | 4.38 |
| Influenza | 5.51 | 5.78 | 6.12 | 6.43 | 6.75 | 7.14 | 7.47 | 7.88 | 8.34 | 8.76 |
| RSV (Respiratory Syncytial Virus) | 8.21 | 8.69 | 9.11 | 9.59 | 10.12 | 10.68 | 11.26 | 11.83 | 12.45 | 13.18 |
| Tuberculosis | 10.97 | 11.56 | 12.14 | 12.78 | 13.50 | 14.21 | 14.93 | 15.81 | 16.60 | 17.51 |
| Streptococcus Testing | 13.70 | 14.41 | 15.21 | 16.01 | 16.88 | 17.72 | 18.73 | 19.70 | 20.73 | 21.84 |
| Other | 16.43 | 17.29 | 18.19 | 19.21 | 20.22 | 21.32 | 22.46 | 23.62 | 24.93 | 26.25 |
Infectious Respiratory Disease Diagnostics Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunoassay | 5.82 | 6.07 | 6.37 | 6.73 | 7.16 | 7.47 | 7.98 | 8.29 | 8.81 | 9.17 |
| Molecular Diagnostics | 11.48 | 12.15 | 12.77 | 13.47 | 14.14 | 14.97 | 15.69 | 16.61 | 17.47 | 18.39 |
| Microbiology | 17.23 | 18.18 | 19.15 | 20.23 | 21.22 | 22.36 | 23.58 | 24.79 | 26.13 | 27.62 |
| Other | 23.01 | 24.23 | 25.57 | 26.85 | 28.34 | 29.84 | 31.38 | 33.14 | 34.84 | 36.73 |
Infectious Respiratory Disease Diagnostics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.76 | 6.09 | 6.40 | 6.79 | 7.16 | 7.48 | 7.93 | 8.32 | 8.80 | 9.25 |
| LAMEA | 11.51 | 12.19 | 12.77 | 13.51 | 14.19 | 14.89 | 15.74 | 16.56 | 17.42 | 18.33 |
| Europe | 17.25 | 18.18 | 19.17 | 20.12 | 21.24 | 22.38 | 23.58 | 24.85 | 26.19 | 27.62 |
| Asia-Pacific | 23.03 | 24.17 | 25.52 | 26.86 | 28.27 | 29.89 | 31.38 | 33.10 | 34.85 | 36.73 |
Infectious Respiratory Disease Diagnostics Market Size to Hit USD 91.91 Billion by 2034
The global infectious respiratory disease diagnostics market size surpassed USD 57.55 billion in 2025 and is predicted to reach around USD 91.91 billion by 2034 with a registering a CAGR of 5.34%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
